Aakaar Medical Technologies Peer Comparison

NSE: AAKAAR

₹63.50

₹-2.50 (-3.79%)

As on 01-Sep-2026IST

Market cap

₹90 Cr

Revenue (TTM)

₹67 Cr

P/E Ratio

13.6

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Market cap (₹ Cr)	90	16,799	16,456	7,524	6,161
Revenue (₹ Cr)	67	4,537	3,915	2,966	1,240
Net Profit (₹ Cr)	6.64	188.20	753.50	284.04	223.00
Net Margin (%)	9.79	4.14	18.85	9.37	17.60
RoE (%)	17.06	3.99	25.89	18.77	31.86
Price to Earnings	13.56	89.26	21.99	26.49	27.63
Price-To-Book	1.65	2.83	5.37	4.61	7.47

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Operating Revenue	66.96	3,961.00	3,779.51	2,944.29	1,164.71
Total Income	67.77	3,974.80	3,864.63	3,011.85	1,192.50
Total Expenditure	56.65	3,458.70	2,815.88	2,494.43	944.46
EBITDA	10.31	502.30	963.64	449.86	220.26
Depreciation	0.13	146.70	177.34	61.24	15.35
EBIT	10.18	355.60	786.30	388.62	204.91
Interest	1.80	98.10	11.13	4.99	1.61
Other Income	0.80	13.80	85.11	67.56	27.79
Exceptional Items	--	-40.80	-10.15	--	--
Profit before Tax	9.19	230.50	846.06	451.19	231.37
Provision for Tax	2.55	33.30	70.81	118.00	41.19
Profit after Tax	6.64	197.20	775.26	333.19	190.18

Liabilities (₹ Cr)

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Shareholder's Funds	54.55	5,826.00	2,923.98	1,588.61	754.98
Minority Interest	--	--	-1.54	--	--
Non-Current Liabilities	0.51	3,635.40	-550.41	643.35	15.59
Current Liabilities	23.90	728.50	838.25	676.31	173.98
Total Liabilities	79.44	10,189.90	3,830.51	2,911.23	945.13

Assets (₹ Cr)

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Non-Current Assets	2.33	8,823.20	1,275.41	1,295.42	337.06
Current Assets	76.63	1,366.70	1,934.86	1,612.85	607.49
Total Assets	79.44	10,189.90	3,830.51	2,911.23	945.13
Total Debt*	18.53	3,186.40	122.38	0.00	0.00
Net Current Assets	52.73	638.20	1,096.61	936.54	433.52
Contingent Liabilities	--	450.40	10.99	9.61	9.94

Cashflow (₹ Cr)

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Cash From Operating Activities	-8.36	226.40	800.53	412.13	196.92
Cash Flow from Investing Activities	0.05	-2,909.90	-181.14	-276.95	-14.45
Cash from Financing Activities	18.80	2,698.40	-554.48	-159.77	-196.49
Net Cash Inflow / Outflow	10.48	14.90	64.91	-24.59	-14.02

Ratios

Profitability Ratios

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
ROCE (%)	18.45	4.42	29.54	30.71	31.00
ROE (%)	17.06	3.43	27.60	22.46	25.33
ROA (%)	9.85	2.39	24.93	12.18	20.61
EBIT Margin (%)	16.60	13.03	27.75	17.57	21.30
Net Margin (%)	9.79	4.96	20.06	11.06	15.95
Cash Profit Margin (%)	10.10	8.22	25.20	10.40	17.65

Growth Ratios

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Revenue Growth (%)	8.74	46.22	-0.78	3.53	20.72
EBIT Growth (%)	11.75	31.22	-4.07	-6.82	52.19
Net Profit Growth (%)	10.03	-43.15	-3.42	-10.23	51.83
EPS Growth (%)	-19.09	-43.15	-3.87	-10.23	59.31
Book Value Growth (%)	134.54	2.72	8.50	14.81	0.78

Valuation Ratios

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Price / Earnings	10.27	68.71	22.13	21.72	23.83
Price / Book Value	1.25	2.33	5.87	4.56	6.01
Dividend Yield (%)	0.00	0.28	2.54	1.78	0.00
EV/EBITDA	6.34	32.21	16.09	13.39	18.11
Market Cap (₹ Cr)	68.17	13,549.79	17,158.99	7,237.65	4,532.48

Solvency Ratios

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Debt to Equity	0.34	0.55	0.04	0.00	0.00
Short term debt to equity ratio	0.34	0.03	0.04	--	--
Current Ratio	3.21	1.88	2.31	2.38	3.49
Quick Ratio	2.38	0.83	1.83	1.88	3.11
Interest Coverage	6.12	3.35	77.02	91.42	144.60

Operating Efficiency Ratios

	Aakaar Medical Technologies	Zydus Wellness	Emami	Jyothy Labs	Bajaj Consumer
Debtors to sales (%)	55.59	9.69	9.08	8.72	6.49
Asset Turnover	0.99	0.51	1.22	1.39	1.26
Receivable days	177.77	32.76	38.37	25.54	23.11
Inventory Days	93.49	55.91	34.17	32.35	18.94
Payable days	34.92	103.68	146.36	70.92	36.67
Cash Conversion Cycle	236.35	-15.02	-73.82	-13.03	5.38

Annual
Quarterly